Announcements Trials
Browse Landscape

Status

Completed 4Active not recruiting 4Recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 3Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Oligospermia 1Non-Muscle Invasive Bladder Neoplasms 1Fibrosis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Epirubicin 3Gemcitabine 2tislelizumab 1lornoxicam 1catumaxomab 1avelumab 1apatorsen 1VB4-845 1Ty21a typhoid vaccine 1Therapeutics 1Radiotherapy 1Postoperative Period 1Ofloxacin 1Multiparametric Magnetic Resonance Imaging 1Mitomycin 1Docetaxel 1Cystoscopy 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Non-Muscle Invasive Bladder Neoplasms × BCG Vaccine × Clear all
NCT05332353 2022-04-18

Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

Mansoura University

Unknown
100 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡